Gan & Lee Pharmaceuticals. (SHA:603087)

SHA:603087 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	39,135	26,332	31,066	18,429	39,499	74,247
Market Cap Growth	59.90%	-15.24%	68.57%	-53.34%	-46.80%	-
Enterprise Value	35,971	21,268	26,918	13,463	34,935	70,382
Last Close Price	65.75	43.35	50.98	31.55	67.67	126.80
PE Ratio	41.78	42.84	91.35	-	27.19	60.33
Forward PE	32.07	11.40	11.40	11.40	25.81	50.01
PS Ratio	10.17	8.65	11.91	10.76	10.94	22.09
PB Ratio	3.47	2.38	2.89	1.92	3.89	8.31
P/TBV Ratio	3.55	2.44	2.97	1.98	4.00	8.54
P/FCF Ratio	-	272.84	-	-	102.30	112.63
P/OCF Ratio	70.65	49.01	283.83	62.12	36.64	59.81
EV/Sales Ratio	9.35	6.98	10.32	7.86	9.67	20.94
EV/EBITDA Ratio	35.49	38.98	67.16	-	22.24	44.70
EV/EBIT Ratio	48.70	72.20	149.52	-	25.13	49.75
EV/FCF Ratio	-163.52	220.38	-	-	90.48	106.77
Debt / Equity Ratio	0	0	0.00	0.00	0.00	-
Debt / EBITDA Ratio	0.00	0.01	0.02	-	0.01	-
Debt / FCF Ratio	-	0.05	-	-	0.05	-
Asset Turnover	0.32	0.26	0.23	0.16	0.36	0.43
Inventory Turnover	0.88	0.81	0.96	0.68	0.70	0.64
Quick Ratio	5.40	3.31	6.77	6.05	12.65	13.14
Current Ratio	7.20	4.73	7.99	6.97	14.15	14.54
Return on Equity (ROE)	8.23%	5.64%	3.35%	-4.45%	15.21%	17.08%
Return on Assets (ROA)	3.79%	1.55%	1.01%	-3.94%	8.54%	11.39%
Return on Invested Capital (ROIC)	8.18%	3.95%	3.34%	-13.72%	25.40%	29.71%
Return on Capital Employed (ROCE)	6.40%	2.60%	1.60%	-6.90%	13.40%	15.60%
Earnings Yield	2.37%	2.33%	1.09%	-2.38%	3.68%	1.66%
FCF Yield	-0.56%	0.37%	-1.43%	-3.73%	0.98%	0.89%
Dividend Yield	2.27%	3.46%	0.39%	-	0.44%	0.32%
Payout Ratio	97.17%	68.42%	-	-	15.46%	16.30%
Buyback Yield / Dilution	0.16%	-4.28%	-0.58%	-0.46%	-5.28%	-5.43%
Total Shareholder Return	2.43%	-0.82%	-0.19%	-0.46%	-4.84%	-5.12%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.